Review: Balancing the efficacy and toxicity of chemotherapy in colorectal cancer

As the therapeutic options for the treatment of colorectal cancer have expanded over the past 20 years, so has the complexity of decision making. The goals of treatment in the palliative, adjuvant and neoadjuvant settings vary and it is not only the efficacy of drugs that influence treatment decisio...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic advances in medical oncology Vol. 3; no. 1; pp. 43 - 52
Main Authors Braun, Michael S, Seymour, Matthew T
Format Journal Article
LanguageEnglish
Published 01.01.2011
Subjects
Adjuvants
Age
Chemotherapy
Colorectal cancer
Decision making
Longevity
Quality of life
Toxicity
Online AccessGet full text

Cover

More Information
Summary:As the therapeutic options for the treatment of colorectal cancer have expanded over the past 20 years, so has the complexity of decision making. The goals of treatment in the palliative, adjuvant and neoadjuvant settings vary and it is not only the efficacy of drugs that influence treatment decisions. Age, performance status, the presence of significant comorbidities and the different treatment regimens and strategies provide medical oncologists with an array of options to attempt to maximize patients' quality of life and longevity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-1
ISSN:1758-8340